AAAAAA
Results:
1-25
|
Results: 25
Authors:
TANCHOT C
GUILLAUME S
DELON J
BOURGEOIS C
FRANZKE A
SARUKHAN A
TRAUTMANN A
ROCHA B
Citation: C. Tanchot et al., MODIFICATIONS OF CD8(-CELL FUNCTION DURING IN-VIVO MEMORY OR TOLERANCE INDUCTION() T), Immunity, 8(5), 1998, pp. 581-590
Authors:
KIRCHNER GI
FRANZKE A
BUER J
BEIL W
PROBSTKEPPER M
WITTKE F
OVERMANN K
LASSMANN S
HOFFMANN R
KIRCHNER H
GANSER A
ATZPODIEN J
Citation: Gi. Kirchner et al., PHARMACOKINETICS OF RECOMBINANT HUMAN INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA PATIENTS FOLLOWING SUBCUTANEOUS APPLICATION, British journal of clinical pharmacology, 46(1), 1998, pp. 5-10
Authors:
SARUKHAN A
LANOUE A
FRANZKE A
BROUSSE N
BUER J
VONBOEHMER H
Citation: A. Sarukhan et al., CHANGES IN FUNCTION OF ANTIGEN-SPECIFIC LYMPHOCYTES CORRELATING WITH PROGRESSION TOWARDS DIABETES IN A TRANSGENIC MODEL, EMBO journal, 17(1), 1998, pp. 71-80
Authors:
BUER J
LANOUE A
FRANZKE A
GARCIA C
VONBOEHMER H
SARUKHAN A
Citation: J. Buer et al., INTERLEUKIN-10 SECRETION AND IMPAIRED EFFECTOR FUNCTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-RESTRICTED T-CELLS ANERGIZED IN-VIVO, The Journal of experimental medicine, 187(2), 1998, pp. 177-183
Authors:
HOFFMANN R
MULLER I
NEUBER K
LASSMANN S
BUER J
PROBST M
OEVERMANN K
FRANZKE A
KIRCHNER H
GANSER A
ATZPODIEN J
Citation: R. Hoffmann et al., RISK AND OUTCOME IN METASTATIC MALIGNANT-MELANOMA PATIENTS RECEIVING DTIC, CISPLATIN, BCNU AND TAMOXIFEN FOLLOWED BY IMMUNOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON ALPHA2A, British Journal of Cancer, 78(8), 1998, pp. 1076-1080
Authors:
FRANZKE A
PROBSTKEPPER M
BUER J
DUENSING S
HOFFMANN R
WITTKE F
VOLKENANDT M
GANSER A
ATZPODIEN J
Citation: A. Franzke et al., ELEVATED PRETREATMENT SERUM LEVELS OF SOLUBLE VASCULAR CELL-ADHESION MOLECULE-1 AND LACTATE-DEHYDROGENASE AS PREDICTORS OF SURVIVAL IN CUTANEOUS METASTATIC MALIGNANT-MELANOMA, British Journal of Cancer, 78(1), 1998, pp. 40-45
Authors:
BUER J
PROBST M
DUENSING S
KODITZ H
FRANZKE A
DALLMANN I
GANSER A
ATZPODIEN J
Citation: J. Buer et al., CLINICAL AND IN-VITRO RESPONSE TO 13-CIS-RETINOIC ACID IN INTERFERON-ALPHA RESISTANT RENAL-CELL CARCINOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(3), 1997, pp. 143-147
Authors:
ATZPODIEN J
KIRCHNER H
FRANZKE A
WANDERT T
PROBST M
BUER J
DUENSING S
WITTKE F
HOFFMANN R
GANSER A
Citation: J. Atzpodien et al., A RANDOMIZED CLINICAL-TRIAL COMPARING SC INTERLEUKIN-2, SC INTERFERON-ALPHA-2A, AND IV BOLUS B-FLUOROURACIL AGAINST ORAL TAMOXIFEN IN PROGRESSIVE METASTATIC RENAL-CELL CARCINOMA PATIENTS, European journal of cancer, 33, 1997, pp. 151-151
Authors:
FRANZKE A
PROBST M
BUER J
WITTKE F
HOFFMANN R
KIRCHNER H
GANSER A
ATZPODIEN J
Citation: A. Franzke et al., AUTOIMMUNITY INDUCED BY INTERLEUKIN-2 AND INTERFERON-ALPHA IS ASSOCIATED WITH LONG-TERM SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, European journal of cancer, 33, 1997, pp. 163-163
Authors:
ATZPODIEN J
FRANZKE A
PROBSTKEPPER M
BUER J
VOLKENANDT M
WITTKE F
HOFFMANN R
GANSER A
Citation: J. Atzpodien et al., SOLUBLE VCAM-1 AS PREDICTOR OF SURVIVAL IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA, European journal of cancer, 33, 1997, pp. 1164-1164
Authors:
DUENSING S
SCHUHKNECHT S
FRANZKE A
BUER J
PROBSTKEPPER M
HOFFMANN R
GANSER A
ATZPODIEN J
Citation: S. Duensing et al., INHIBITION OF SPONTANEOUS APOPTOTIC CELL-DEATH OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) CELLS BY INTERLEUKIN-12 IN-VITRO, European journal of cancer, 33, 1997, pp. 1200-1200
Authors:
MUMMENHOFF K
FRANZKE A
KOCH M
Citation: K. Mummenhoff et al., MOLECULAR-DATA REVEAL CONVERGENCE IN FRUIT CHARACTERS USED IN THE CLASSIFICATION OF THLASPI S. L. (BRASSICACEAE), Biological Journal of the Linnean Society, 125(3), 1997, pp. 183-199
Authors:
BOKEMEYER C
FRANZKE A
HARTMANN JT
SCHOBER C
ARSENIEV L
METZNER B
LINK H
KANZ L
SCHMOLL HJ
Citation: C. Bokemeyer et al., A PHASE I II STUDY OF SEQUENTIAL, DOSE-ESCALATED, HIGH-DOSE IFOSFAMIDE PLUS DOXORUBICIN WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR THE TREATMENT OF PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMAS/, Cancer, 80(7), 1997, pp. 1221-1227
Authors:
MUMMENHOFF K
FRANZKE A
KOCH M
Citation: K. Mummenhoff et al., MOLECULAR PHYLOGENETICS OF THLASPI SL (BRASSICACEAE) BASED ON CHLOROPLAST DNA RESTRICTION SITE VARIATION AND SEQUENCES OF THE INTERNAL TRANSCRIBED SPACERS OF NUCLEAR RIBOSOMAL DNA, Canadian journal of botany, 75(3), 1997, pp. 469-482
Authors:
BUER J
PROBST M
FRANZKE A
DUENSING S
HAINDL J
VOLKENANDT M
WITTKE F
HOFFMANN R
GANSER A
ATZPODIEN J
Citation: J. Buer et al., ELEVATED SERUM LEVELS OF S100 AND SURVIVAL IN METASTATIC MALIGNANT-MELANOMA, British Journal of Cancer, 75(9), 1997, pp. 1373-1376
Authors:
DECKERT M
FRANZKE A
BUER J
PROBST M
DUENSING S
LOPEZHAENNINEN E
KIRCHNER H
POLIWODA H
ATZPODIEN J
Citation: M. Deckert et al., LINOMIDE AND INTERLEUKIN-2 IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 319-324
Authors:
BUER J
HILSE R
DALLMANN I
GROSSE J
KIRCHNER H
ZORN U
HANNINEN EL
FRANZKE A
DUENSING S
POLIWODA H
ATZPODIEN J
Citation: J. Buer et al., LYMPHOCYTE-CONDITIONED MEDIUM IN COMBINATION WITH INTERLEUKIN-2 EFFECTIVELY INDUCES ANTITUMOR AUTOIMMUNITY BY ADOPTIVE TRANSFER OF SHORT ACTIVATED KILLER (SHAK) CELLS, Cytokines and molecular therapy, 1(1), 1995, pp. 39-46
Authors:
ATZPODIEN J
HANNINEN EL
KIRCHNER H
FRANZKE A
KORFER AK
VOLKENANDT M
DUENSING S
SCHOMBURG A
CHAITCHIK S
POLIWODA H
Citation: J. Atzpodien et al., CHEMOIMMUNOTHERAPY OF ADVANCED MALIGNANT-MELANOMA - SEQUENTIAL ADMINISTRATION OF SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA AFTER INTRAVENOUS DACARBAZINE AND CARBOPLATIN OR INTRAVENOUS DACARBAZINE, CISPLATIN, CARMUSTINE AND TAMOXIFEN, European journal of cancer, 31A(6), 1995, pp. 876-881
Authors:
ATZPODIEN J
KIRCHNER H
DUENSING S
HANNINEN EL
FRANZKE A
BUER J
PROBST M
ANTON P
POLIWODA H
Citation: J. Atzpodien et al., BIOCHEMOTHERAPY OF ADVANCED METASTATIC RENAL-CELL CARCINOMA - RESULTSOF THE COMBINATION OF INTERLEUKIN-2, ALPHA-INTERFERON, 5-FLUOROURACIL, VINBLASTINE, AND 13-CIS-RETINOIC ACID, World journal of urology, 13(3), 1995, pp. 174-177
Authors:
ATZPODIEN J
PROBST M
KIRCHNER H
BUER J
DUENSING S
FRANZKE A
SCHOBER C
KODITZ H
GEISSLER RG
GANSER A
Citation: J. Atzpodien et al., 13-CIS-RETINOIC ACID IN CML BLAST CRISIS - CLINICAL AND PRECLINICAL EVALUATION, Blood, 86(10), 1995, pp. 3146-3146
Authors:
DUENSING S
MEYER N
GROSSE J
FRANZKE A
BUER J
PROBST M
KIRCHNER H
GANSER A
ATZPODIEN J
Citation: S. Duensing et al., LOSS OF VLA-3 (ALPHA-3-BETA-1 INTEGRIN) EXPRESSION IN A HUMAN BURKITTS-LYMPHOMA CELL-LINE EXPOSED TO VINCRISTINE, Blood, 86(10), 1995, pp. 3233-3233
Authors:
ATZPODIEN J
KIRCHNER H
HANNINEN EL
MENZEL T
DECKERT M
FRANZKE A
SCHOMBURG A
POLIWODA H
Citation: J. Atzpodien et al., TREATMENT OF METASTATIC COLORECTAL-CANCER PATIENTS WITH 5-FLUOROURACIL IN COMBINATION WITH RECOMBINANT SUBCUTANEOUS HUMAN INTERLEUKIN-2 ANDALPHA-INTERFERON, Oncology, 51(3), 1994, pp. 273-275
Authors:
ATZPODIEN J
KIRCHNER H
KORFER A
HADAM M
SCHOMBURG A
MENZEL T
DECKERT M
FRANZKE A
VOLKENANDT M
DALLMANN I
GROSSE J
POLIWODA H
Citation: J. Atzpodien et al., EXPANSION OF PERIPHERAL-BLOOD NATURAL-KILLER-CELLS CORRELATES WITH CLINICAL OUTCOME IN CANCER-PATIENTS RECEIVING RECOMBINANT SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA(2), Tumor biology, 14(6), 1993, pp. 354-359
Authors:
ATZPODIEN J
KIRCHNER H
HANNINEN EL
KORFER A
FENNER M
MENZEL T
DECKERT M
FRANZKE A
JONAS U
POLIWODA H
Citation: J. Atzpodien et al., EUROPEAN STUDIES OF INTERLEUKIN-2 IN METASTATIC RENAL-CELL CARCINOMA, Seminars in oncology, 20(6), 1993, pp. 22-26
Authors:
ATZPODIEN J
MEFFERT M
HANNINEN EL
DECKERT M
FRANZKE A
KIRCHNER H
POLIWODA H
Citation: J. Atzpodien et al., INTERLEUKIN-2 INDUCED TUMOR-NECROSIS-FACTOR-ALPHA AS PREDICTOR OF SURVIVAL IN ADVANCED TUMOR PATIENTS, Blood, 82(10), 1993, pp. 10000515-10000515
Risultati:
1-25
|